New Project Pharmaceuticals in the Environment
At Moehs Group, we continue to advance our commitment to sustainability as a member of the Pharmaceutical Supply Chain Initiative (PSCI). One of our priorities
XXII Conference on Good Manufacturing Practice for Medicines and Active Ingredients
Last 10th of December, our Site Manager, Josep Mª Casanovas, presented how we work at Moehs Group to continuously improve in the efficient use of
Moehs Group at the Pharmaceutical Manufacturing Catskills Training 2024
On 15th of November, Moehs Group team had the pleasure of collaborating in the Pharmaceutical Manufacturing Catskills 2024 training, organized at INS La Romànica, in
Moehs Group and EUROAPI sign an exclusive agreement for the production of Metamizole in Europe.
Moehs Group, a leading international group in the production of active pharmaceutical ingredients, has signed an exclusive agreement with EUROAPI to take over the production
CO2 EMISSION SAVINGS
At Moehs Group we are very committed to caring for our planet and our activity strictly complies with each and every one of our commitments.
2 GRANTS FROM CENTRO PARA EL DESARROLLO TECNOLÓGICO Y LA INNOVACIÓN
The Administration Board of the Centro para el Desarrollo Tecnológico y la Innovación, E.P.E (CDTI), has approved 2 important grants for Moehs Group: ABROCITINIB: development
VISIT TO EMIRATES FACILITIES
The traffic department of Moehs Group has had the opportunity to visit Emirates facilities at Barcelona Airport where they saw, first hand, how the air
Moehs Group member of CataloniaBio & HealthTech
From Moehs Group we would like to announce our incorporation as a member of the CataloniaBio & HealthTech platform. An entity that represents companies in
CARBON FOOTPRINT CERTIFICATE 2023
We are very proud to share the results obtained on the reduction of our carbon footprint! Once again, at Moehs Group, we continue striving and
